F-18 FDG PET/CT practice guideline in oncology: Assesment of treatment response F-18 FDG PET/BT onkolojik uygulama kılavuzu: Tedavi yanıtının belirlenmesi
Nuclear Medicine Seminars, cilt.6, sa.3, ss.358-369, 2021 (Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 6 Sayı: 3
- Basım Tarihi: 2021
- Doi Numarası: 10.4274/nts.galenos.2020.0029
- Dergi Adı: Nuclear Medicine Seminars
- Derginin Tarandığı İndeksler: Scopus, EMBASE
- Sayfa Sayıları: ss.358-369
- Anahtar Kelimeler: FDG PET/CT, PERCIST, RECIST, Response assessment
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Assessing response to treatment is an important parameter in oncology practice and there is a growing body of evidence for use of F-18 fludeoxyglucose (FDG) positron emission tomography/computerized tomography (PET/CT) to evaluate response during or after the treatment. The use of FDG PET/ CT for this indication is increasing due to its advantages such as enabling rapid evaluation of all lesions and body parts in a single session, assessing viability in residual masses, not being limited to size measurements and low inter-observer variability. Many evaluation criteria have been proposed for standardization and interpretation of PET/CT findings. This guideline aims to provide a brief overview of proposed criteria and assist Nuclear Medicine Physicians in interpreting FDG PET/CT findings for the evaluation of the response.